Who owns Exagen Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Exagen with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Exagen stock

Who bought or sold Exagen Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Cowen And Company 899k $1.4M 0% Mar 2024
 View chart
Daniel D. Thurber 787k $1.3M -7% Mar 2024
 View chart
Silvercrest Asset Management Group 545k $866k 0% Mar 2024
 View chart
Perkins Capital Management 494k $785k -3% Mar 2024
 View chart
Vanguard Group 491k $781k 0% Mar 2024
 View chart
Morgan Stanley 482k $767k 0% Mar 2024
 View chart
Geode Capital Management 82k $130k 0% Mar 2024
 View chart
Penbrook Managment 77k $122k 1% Mar 2024
 View chart
Nantahala Capital Management 74k $118k -23% Mar 2024
 View chart
UBS Group 63k $99k 0% Mar 2024
 View chart
BlackRock 56k $88k -17% Mar 2024
 View chart
Bridgeway Capital Management 41k $65k 0% Mar 2024
 View chart
Dimensional Fund Advisors 26k $42k -27% Mar 2024
 View chart
Millennium Management 24k $38k 1% Mar 2024
 View chart
Palumbo Wealth Management 18k $29k 100% Mar 2024
 View chart
Northern Trust 16k $26k 0% Mar 2024
 View chart
First Bank & Trust 14k $22k 0% Mar 2024
 View chart
Citadel Advisors 13k $21k -38% Mar 2024
 View chart
Hanson McClain Advisors 7.0k $11k 0% Mar 2024
 View chart
Bank of America Corporation 6.0k $9.6k 0% Mar 2024
 View chart
Barclays 5.1k $8.0k 0% Mar 2024
 View chart
Tower Research Capital 4.0k $6.4k 100% Mar 2024
 View chart
Wells Fargo & Company 2.5k $3.9k 0% Mar 2024
 View chart
Qube Research & Technologies 204.00 $323.992800 0% Mar 2024
 View chart
Royal Bank of Canada 88.00 $0 -84% Mar 2024
 View chart
Jpmorgan Chase & Co 34.00 $54.400000 36% Mar 2024
 View chart